Semaglutide is a GLP-1 receptor agonist initially developed to treat type 2 diabetes
This oral peptide formulation is designed for individuals seeking gastrointestinal support and systemic healing benefits through convenient capsule administration
No Randomized Controlled Trials: As of February 2026, no published, peer-reviewed, randomized controlled trial of BPC-157 in humans exists for any indication
However, its crucial to clarify that the research on BPC-157 for use in humans is still in its infancy, with most of the peptide's potential benefits based on the results of animal or cell studies
Cognitive function : B12 is involved in maintaining brain health and can support memory and mood
Our peptides are delivered as lyophilized (freeze-dried) powders, which offer stability against short-term temperature fluctuations during transit